Literature DB >> 21055976

Results of catheter-directed endovascular thrombolytic treatment of acute ischaemia of the leg.

G A Løkse Nilssen1, D Svendsen, K Singh, K Nordhus, D Sørlie.   

Abstract

OBJECTIVES: To observe immediate and late results of catheter-directed endovascular thrombolytic treatment of acute ischaemia of the leg. DESIGN,
MATERIAL AND METHODS: A total of 212 patients treated with Actilyse® at the University Hospital of North Norway because of acute arterial ischaemia of the leg during the period 01 January 2000-30 June 2006 were analysed retrospectively.
RESULTS: The radiologic outcome was judged to be successful in 101 (48%), adequate in 80 (38%) and failed in 31 (14%). At 1-year follow-up, 158 (75%) were alive without amputation, 14 (7%) were alive with amputation, 20 (9%) were dead without amputation and 20 (9%) were dead with amputation. Altogether, 34 (16%) were amputated and 40 (19%) were dead after 1 year. After an average observation period of 3.25 years, 111 (52%) were alive without amputation, 16 (8%) were alive with amputation, 60 (28%) were dead without amputation and 25 (12%) were dead with amputation. A total of 41 (19%) were amputated and 85 (40%) were dead. Fifty complications were registered; 30 (14%) patients had a compartment syndrome, eight (4%) had cerebral stroke and 12 (6%) had a myocardial infarction.
CONCLUSIONS: The results are at least as good as historic controls and similar to international series. Especially, it appears as though the long-term results are somewhat better. The complication rate and morbidity are less than in surgery alone. Copyright Â
© 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21055976     DOI: 10.1016/j.ejvs.2010.09.009

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  1 in total

1.  Catheter-Directed Thrombolysis in the Treatment of Acute Ischemia in Lower Extremities Is Safe and Effective, Especially with Concomitant Endovascular Treatment.

Authors:  Lærke Urbak; Louise de la Motte; Peter Rørdam; Aamir Siddiqi; Henrik Sillesen
Journal:  Ann Vasc Dis       Date:  2017-06-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.